US Patent 11591595 Compositions for modulating Tau expression
Patent 11591595 was granted and assigned to Biogen on February, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11591595 Compositions for modulating Tau expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.